 |
|
  |
|
July 2006 |
Science in India Newsletter
|
|
Science & Technology Newsletter India – July 2006 |
|
 |
|
|
|
Index
S&T Policies:
1.
India – US Joint Industry working group for biotechnology
2. Creation of Ministry of
Earth Sciences
3. Traditional Knowledge
Digital Library (TKDL)
4. India can become
significant global Biotech player by 2010
5. India has an edge over
China in Biotech - R&D and quality control areas
6. India ahead of China in
Biotech regulatory aspects
7. Guidelines for Stem Cell
Research and Therapy
8. India among top 10 growers of biotech crops
9. Project to boost
agricultural research
10. Clinical trial: DCGI plans
to work with USFDA
11. Incite-ing – Indian
participation in EU research
12. Indo-German energy
cooperation
Research:
13. New gene responsible
for pancreatits identified
14. Asians not likely to pass TB to europeans
15. Curcumin kills malaria
parasites 16.
Fusion Research 17. Scientists create knockout mouse strain
18. Buried in time:
culturable fungi from deep-sea sediments
19. Indian lead molecule for
malaria bags US patent
20. Indian scientists identify new pathway to
combat TB
21. SERC – a portrait
22. ISRO begins work on navigational satellite
system
Academic Exchange/ Education:
23. National Technology
Day celebrated 24. New Business Master’s Programme in India by ESCT-EAP Berlin
25. 56th Meeting of Nobel
Laureates in Lindau
Miscellaneous:
26. Bangalore Bio 2006 -
Highlights 27.
Bangalore Bio – announcements
28. Indian moon mission to
carry US radar, mineral mapper
29. Icrisat unveils vision
2015 document
30. Success story – Indo-
German cooperation
31. Indo- German project
V-Mia
32. SAP India plans
expansion
33. Mathematics: King
Faizal prize for M.S. Narasimhan
34. Indian engineers help
craft futuristic cell phone chip
35. European-Indian
cooperation in robotics and clean room technology
|
|
1.
India – US Joint Industry working group for biotechnology
India-US joint industry working group for
biotechnology has decided to prepare a comprehensive report in
three areas: transfer of biomaterials, clinical research and
new product development and innovation.
The Indo-US industry working group in biotechnology has been
set up under the High Technology Cooperation Group (HTCG)
between the two countries. It is coordinated by Federation of
Indian Chamber of Commerce and Industry, New Delhi (FICCI) and
US India Business Council (USIBC).
(Press Release Indian Government 22.05.2006, PRA:MV:NC)

The Indian government has
restructured the Department of Ocean Development into a
Ministry of Earth Sciences. The ministry will consist of two
major entities – Ocean Science and Technology Department and
India Meteorological Department. It will be headed by Science
and Technology Minister Kapil Sibal. He said that the country
cannot reach the 10% growth rate unless science and technology
assumes a role in the front.
(PTI Science Service, 16.-31.05.2006)

|
|
Traditional Knowledge
Digital Library (TKDL) is an application for inventorisation
of Traditional Knowledge (TK) to preserve and protect the
Indian Traditional Knowledge from bio-piracy at
international level. It was conceptualized by the National
Institute of Science Communication and Information Resources
(NISCAIR), New Delhi and was officially launched on 26 March
2002. The first project phase led to the release of a CD on
TKDL-Ayurveda with information in 14 authentic Ayurvedic
texts in patent application format, compromising 36.000
formulations. Next areas include Unani, Siddha and Yoga
systems of medicine.
TKDL has become a model for other countries for replication.
The World Health Organisation (WHO) has pointed out that the
system should be replicated and the UNESCO discovered its
usefulness for inventorisation of intangible cultural
heritage.
(CSIR News, Vol 56 Supplement May 2006,
http://203.200.90.6/tkdl/LangDefault/common/Home.asp?GL=Eng)

|
|
The global biotechnology
industry is pegged at $54 billion and is growing currently at
17 percent annually. The Indian biotechnology market is
growing at a pace of 36.5 percent per annum which is one of
the highest in the world today. India, which ranks among the
top 10 biotech hubs of the world, would join the elite club of
top 5 biotech hubs, should it achieve the $5 billion mark (10%
of the global market) by 2010.
India is already in a pivotal position to secure a significant
share in important segments such as vaccines, diagnostics and
clinical trials. It is considered that India already has the
largest vaccine production capacity in the world.
Even if 15 percent of all clinical trials were to be
outsourced in the next 3 years and predictions made by BCC
Research come true, $4 billion worth of clinical trials will
be conducted in developing countries. (Source: Economic Times,
Nov 2004) and a large part of this opportunity can be secured
by the Indian biotech industry. It is estimated that India can
attract around $250-300 million of the global clinical trials
market by 2010. (Source: Centre Watch, Aug 2003).
Considering the growth rate to be constant at around 30
percent, the biopharma segment has the potential to reach an
estimated value of $3 billion by 2010. (Source: Ernst & Young)
(Biospectrum, Issue 4, April 2006,
full article)

|
|
Prof. Kazuo N Watanabe of the
Gene Research Center & Graduate School for Life and
Environmental Sciences, University of Tsukuba, Japan, was in
India to participate in BioAsia 2006 held in Hyderabad in
February. He spoke to BioSpectrum about the biotechnology
industry in Japan. Excerpts of the interview at:
http://www.biospectrumindia.com/content/BioClusters/10604113.asp
(Biospectrum. Issue 4, April 2006)

|
|
Interview with Robert A
Honor, vice president - life sciences, Rockwell Automation:
Which is an emerging market in the Asia Pacific region for
your range of products?
In the Asia Pacific region, India and China are clearly
putting in a lot of efforts in pharmaceuticals and
biotechnology sectors. I put India a little ahead of China
mainly because of regulatory aspects, for having more US FDA
audited facilities outside the US in the world.
We see great opportunity for our range of products in India
owing to a couple of factors. First, the growth of the
industry by itself will provide a great opportunity. Second,
the export nature. A lot of our products and services will
build Indian capabilities to meet the process requirements of
the global standards so as to go to the international market.
The regulatory aspect is one factor and then the overall
growth of the industry and investments that is the need of the
industry itself makes us to look at India.
(Biospectrum, Issue 4, April 2006)

|
|
In 2005, India accounted
for the highest yearly percentage growth rate increasing its
Biotech cotton area by 160 percent. With this India became the
seventh largest adopter of biotech crop, according to a report
authored by Dr Clive James, chairman and founder of ISAAA, the
International Service for the Acquisition of Agri-biotech
Applications.
(Biospectrum. Issue 4, April 2006,
full article)
|
|
8.
Guidelines on stem cell research
Guidelines on stem cell
research will released in the near future. The Indian Council
of Medical Research / Department of Biotechnology (DBT)
guidelines are in their final phase of preparation. The Indian
government is strongly promoting stem cell research in the
country. To this end, a stem cell society has been established
and the institutional infrastructure in institutes
strengthended, like All India Institute of Medical Sciences (AIIMS),
Post Graduate Institute (Chandigarh) and National Centre of
Brain Research (NBRC).
(PTI, Science Service, 16.-31.01.2006)

|
|
The government has approved
two projects to boost research and education in agricultural
science. The Rs. 1,190 crore (ca. 200 Mio. EUR) National
Agricultural Innovation Project (NAIP) aims to give a strong
impetus to agricultural research. Research will be done in
frontier areas of agricultural sciences. The components of the
project would be implemented by a network of public research
institutions, private sector, NGOs and other stakeholders.
(The Economic Times, 30.06.2006)

|
|
Drug Controller General of
India, Department Biotechnology (DBT), Delhi and Indian
Council of Medical Research (ICMR), Delhi are exploring
chances of working jointly with the US Food and Drug
Administration to put an appropriate regulatory, monitoring
and enforcement mechanism in place to conduct clinical trials
and research in India.
Paolo Miotti, a scientist at the US-based National Institute
of Health (NIH), who has been appointed as facilitator for the
US embassy at New Delhi, said US supported India’s plan to
raise the capability of its drug approving agency.
The clinical research industry in India has increased from 2
mill. Rps (ca. 34.000 EUR) to 10 mill. Rps (ca. 170.000 EUR)
during the last three years. According to a McKinsey report by
2010 the clinical research industry was expected to grow up to
500 mill. Rps (8,3 Mio EUR).
(PTI Science Service, 16.-30.04.2006, The Hindu 07.04.2006:
see article)

|
|
INCITE (Indian Networks
Cooperation in Information Society Technology with Europe)
wants to facilitate IT cooperation between India and Europe in
the R&D sector. Its mission is to spread awareness on the
access to the IST funding programme of the European Commission
to the Indian IT community. The project started in June 2005
with three objectives: helping Indian organisations to access
and benefit from EU-funding, promoting IT cooperation at
research level and setting up a permanent platform for
cooperation. Three events were organised in Bangalore, Pune
and Mumbai. The next round of events will take place in
September in Hyderabad, Chennai and Cochin. Three more are
scheduled in January 2007 in Kolkata, New Delhi and Bangalore.
(EU-India Update, Vol 6, #2,
March/April 2006)

|
|
India and Germany want to
intensify their renewable energy cooperation. During a meeting
with the Indian Minister for Renewable Energies Vilas
Muttemwar, Federal Environment Minister Sigmar Gabriel said
that India is an interesting market for German companies. He
invited India to participate in the international political
network REN 21. India is expanding its industrial field in
wind power, photovoltaic, biomass and hydropower. India will
host the World Wind Power Conference in November 2006.
(www.internationale-kooperation.de,
www.bmu.de)

|
|
Scientists from the Centre
for Cellular and Molecular Biology (CCMB) in Hyderabad and the
Asian Institute of Gastroenterology, Hyderabad have identified
a gene called Cathepsin B, the second candidate gene after
SPINK-I, which is likely to independently cause the disease of
Tropical Calcific Pancreatitis, unique to India and
neighbouring countries.
So far it was assumed that food habits and environmental
factors caused the disease but research by the two institutes
has confirmed the cause is genetic and peculiar to the region.
(PTI Science Service, 16.-30.04.2006
Further information at:
http://gut.bmjjournals.com/cgi/content/abstract/gut.2005.087403v1)
|
|
Latest tuberculosis
research reveals that strains of the virus prevalent in
patients from India differ from those in Pakistan or
Bangladesh and there are negligible chances of Asians passing
the disease to europeans. The study published in the 2005
issue of “The Journal of Microbiology” stated that there was a
noticeable geographical association in the origin and
properties of TB among groups of people from different ages,
countries and ethnic regions living in London.
(PTI Science Service, 16.-30.04.2006
Full article at:
http://www.outlookindia.com/pti_news.asp?id=373853)

|
|
Researchers at the Indian
Institute of Science here have found that curcumin, isolated
from turmeric (“Gelbwurz”), kills malaria parasites.
On the basis of its finding, the team, led by biochemist
Govindarajan Padmanabhan has proposed to the World Health
Organisation a novel artimisinin-curcumin therapy to treat
malaria.
The scientists have been granted a US patent for the invention
which could potentially bring down the cost of treating
malaria, especially the resistant variety.
Padmanabhan said that animal studies done in his laboratory
have proved that curcumin-artimisinin combination is very
effective against malaria. Their report appeared in the May
issue of the journal “clinical therapeutics”.
(PTI Science Service, 16.-30.04.2006, The Hindu 18.04.2006
see article)

|
|
As a major step forward in
fusion research, the Superconducting Steady State Tokamak
(SST-1), a crucial device in a fusion reactor, is expected to
become functional in six months time. India is also
participating in an international initiative on fusion
research, ITER. "While we are participating in ITER, we are
also involved in fusion research independently," Prof P K Kaw,
Director of the Gandhinagar-based Institute of Plasma
Research, said. " The SST-1 was being designed to maintain
plasma for 1000 seconds. Under the country’s plan, scientists
would work on next stage of tokamak, SST-2, during 2015-20
while during 2020-2040, ITER-like experiments are expected to
be done.
(PTI Science Service, 16.-30.04.2006)

|
|
Scientists at the Centre
for Cellular and Molecular Biology (CCMB) Hyderabad have
developed a knockout mouse strain that will go a long way in
creating designer dairy animals with modified milk properties.
This will also help in creating human disease models and in
drug discovery.
The CCMB scientists, led by Dr Satish Kumar, have joined the
select club by genetically engineering a mutant mouse strain
that lacked kappa-casein, one of the important milk protein
genes. Though healthy without the gene, the females lost the
ability to produce milk, Dr Lalji Singh, Director of CCMB,
said.
Though the knockout technology is in vogue for the last 15
years, it is for the first time that kappa-casein is excluded.
(PTI Science Service, 16.-31.05.2006,
Link to Full report)

|
|
The occurrence of paleobes
for the first time from a deep-sea sediment core obtained from
a depth of 5904 m from the Chagos trench in the Indian Ocean
was revealed. Culturable fungi, direct counts of bacteria, age
of the sediments based on the radiolarian assemblage, total
organic carbon, Eh and CaCO sub(3) were determined in these
sediments. The age of the sediments from which fungi were
isolated was estimated to range from greater than 0.18 to 0.43
million years (Ma), being the oldest recorded age for recovery
of culturable fungi. It is proposed that deep-sea sediments
are a source of paleobes, which could be useful in studies on
palaeoclimate, long-term microbial survival and biotechnology.
Patents: The National Institute of Oceanography has filed 36
patent applications. 3 patents were granted in India, 10 in
USA and 1 in UK from diverse fields such as pharmacology,
antifouling and marine instrumentation.
(National Institute of Oceanography, Annual Report 2004/2005)

|
|
Scientists from the
National Institute of Oceanography, Goa in collaboration with
researchers at the National Centre for Cell Science, Pune, and
International Centre for Generic Engineering and Biotechnology
(ICGEB) in New Delhi, have isolated two anti-malarial
molecules from mussels and these molecules may be used in
conjunction with conventional drugs.
Pre-clinical toxicity study of the molecules have shown no
side effect. Clinical trials will begin in two months.
The Council of Scientific and Industrial Research (CSIR) has
been assigned a US patent for the discovery of two promising
compounds NIO-1 and NIO-2 from mussels for the treatment of
malaria.
(Biospectrum. Issue 4, April 2006,
full article)

|
|
A team of Indian scientists
led by Rajesh S Gokhale, an HHMI (Howard Hughes Medical
Institute, Maryland, U.S.) international research scholar at
the National Institute of Immunology in New Delhi, has
identified five key genes that enable Mycobacterium
tuberculosis to acquire the iron it needs to sustain growth
and promote infection.
"Targeting genes within this cluster represents a good
strategy for preventing tuberculosis and other mycobacterial
infections," said Gokhale, the lead investigator on the study.
"Because some of these genes are conserved across a number of
related bacterial families, they are promising targets for
drugs to treat TB and other bacterial diseases."
(Biospectrum. Issue 4, April 2006,
full article)

|
|
The Structural Engineering
Research Centre, Chennai undertook six new sponsored research
projects during 2004-2005. It also participated in a programme
under the New Millennium Indian Technology Leadership
Initiative scheme, on the development of a 500 kW, low cost
Horizontal Axis Wind Turbine with the National Aerospace
Laboratories, Bangalore and Sangeetha Group of Companies.
Other major activities included: static and cyclic tests on
vibration control of buildings under seismic excitation, wind
tunnel investigations, “health monitoring of a fly over bridge
in Visakhapatnam Port Trust”, an analytical study on the
structural response of cold formed panel, development of user
friendly interactive computer programmes and algorithms and
work on the development of an expert system for condition
assessment of bridges. 155 research papers were published,
SERC edited and published the proceedings of the International
conference on advances in concrete composites and structures (ICACS)
2005 and co-edited the proceedings of an Indo-US workshop with
experts from the USA.
(CSIR NEWS, Vol 56 No 10, 30.05.2006, link:
http://www.sercm.org)

|
|
The Indian Space Research
Organisation (ISRO) has begun work on setting up the Indian
Regional Navigational Satellite System (IRNSS) which will be
used to provide location information to users. It will consist
of seven satellites and a large ground segment and it is based
on GEO and inclined GSO satellites. The IRNSS could help open
up opportunities for civil aviation and civil applications.
(The Hindu, 06.07.2006)

|
|
23.
National Technology Day celebrated
S&T Minister Kapil Sibal
said at a function to celebrate National Technology Day that
strategies have to be deployed to develop skilled human
resource in education institutions in order to accelerate
innovation and boost R&D. The Ministry of Science & Technology
will soon introduce a legislation in parliament for sharing
intellectual property rights generated in government funded/
aided research activities and it is hoping to that the level
of R&D expenditure may increase to 2 per cent of the GDP.
(Press Release, Ministry of Science & Technology,
11.05.2206)
|
|
The ESCP-EAP, European
School of Management Berlin introduced the possibility for its
students to pass the first semester at the Management
Development Institute, New Delhi during the 1 year “Master’s
in European Business” (MEB). This programme meets the growing
importance of the Indian economic region and its great
potential for many companies, said Prof. Dr. Stefan Schmid,
Scientific Head of the MEB Programme.
(more information at:
www.escp-eap.de/index.php?id=23 )
|
|
Kapil Sibal, Minister for
Science & Technology and Ocean Development interacted with the
group of young scientists who represented India at the 56th
Meeting of Nobel Laureates & students at Lindau, Germany. The
highly competitively selected Indian team comprised of 26
young scientists and students in the age group 20-30 yrs.
He said that the purpose of the programme is to provide
inspiration from direct interaction with Nobel laureates who
are often simple persons with great sense of purpose and
vision for global issues. The Minister also mentioned that a
Lindau like meeting
may be planned in India so that more Indian students get
opportunity to interact with great minds in science and
students from other parts of the world. In the week after the
Lindau meetings, the Indian team also visited several premier
German institutions in the area of Chemistry and a Chemical
Company.
(Press
Release Indian Government, PRA/MV/NC, 10.07.2006)

|
|
The sixth edition of
BangaloreBio concluded on June 9, 2006 with the last day
dedicated to agri-biotech and intellectual property rights.
The event had attracted delegations from leading biotech
countries including France, Germany, Holland and UK. About 72
national and international speakers, 600 conference delegates,
150 exhibitors from over 20 countries and across India
participated in this premier biotech event in India. The
fourth BioSpectrum-ABLE Indian Biotech Industry survey report
was released. According to this report the country’s biotech
industry grew by 37.42 percent and recorded $1.45 billion in
revenues in the fiscal year 2005-2006.
(www.biospectrumasia.com,
12.06.2006)
|
|
MK Shankaralinge Gowda,
Secretary, Department of IT, Biotechnology and Science &
Technology, Government of Karnataka:
-
The 100 acres biotech park
in Bangalore will be operational by the end of 2006 near
Electronic City. This project has been awarded to the National
Building Construction Company.
-
Karnataka supports
investments from biofuel companies. Citing the example of the
Indian Railways, biofuel farming, where-in 90,000 hectares of
land have been allocated for this purpose.
-
Karnataka has attracted the
highest Venture Capital fund in Asia.
-
Karnataka will support stem
cell banks and other new areas of biotechnology.
Kiran Mazumdar Shaw,
chairperson, Vision Group on Biotechnology and CMD, Biocon
Ltd:
(Biospectrum. Issue 4,
April 2006)
|
|
India’s first mission to
the moon Chandrayaan-1 will carry two US-made instruments that
will look for mineral resources and ice deposits on the lunar
surface. An agreement for including the devices was signed by
Indian Space Research Organisation (ISRO) Chairman Madhavan
Nair and visiting US National Aeronautics and Space
Administration (NASA) chief Michael Griffin. Griffin said that
he was hoping for many more technically challenging and
scientifically rewarding projects with India. The two sides
also want to complete an agreement for the launch of US
satellites and satellites with American components by Indian
rockets. Griffin said that he was sorry about American
sanctions on some Indian space units and would use his good
offices to see that they were lifted.
(PTI Science Service, 16.-31.05.2006)

|
|
The International Crops
Research Institute for the Semi-Arid Tropics (ICRISAT)
Hyderabad has come out with a vision 2015 document to improve
the lot by providing scientific solutions to the poor of the
semi-arid tropics (SAT) in Asia and sub-Saharan Africa in the
next decade.
The strategy would be aligned with the objectives of the
Consultative Group on International Agricultural Research (CGIAR),
a network of 15 international agricultural research
institutes.
Meanwhile, Dr Dar, Director-General of Icrisat, received the
Best Technology Incubator 2005 Award, for Agri-Business
Incubator (ABI) at Icrisat.
(The Hindu Businessline, 16.05.2006,
link to full article)

|
|
Researchers of the
Institute of Environmental Research (INFU; University of
Dortmund) and the Regional Research Laboratory (RLL, Jammu in
Kashmir) succeeded to isolate the active ingredient
Camtothecin from entophytic mushrooms of the seldom plant
Nothapodytes foetida. The active ingredient is an important
precursor for anti-cancer medicine that is successfully being
used against bowel cancer.
(more information at:
www.infu.uni-dortmund.de,
http://www.rrljammu.org)

|
|
Voice based Multilingual
Information Access (V-Mia) is a user oriented Indo-German
language technology project for the introduction of a
multilanguage telephone system. After completion of the first
project phase in 2008 the V-Mia system will enable the access
to train timetables and reservation system of the Indian
Railway in 5 languages via telephone. The project is lead by
Prof. C.N. Krishnan, AU-KBC research Centre, MIT Campus, Anna
University, Chennai and the German Research Centre for
Artificial Intelligence (DFKI, Saarbrücken). Future industrial
partners will include Deutsche Telekom, Siemens and Syspalog
Voice Solutions. (www.dfkai.de,
www.cdacindia.com)

|
|
SAP India will be investing
20 million EUR in expanding its India operations with software
development activities, creation of centres of excellence and
a chain of 22 SAP training centres across the country and
research. The focus is to expand offices and increasing
presence in various industry verticals. New offices were
opened this year in Hyderabad, Chennai and Pune.
(The Hindu Business Line, 15.06.2006)

|
|
As the latest in a row of
international awards and decorations Prof. M.S. Narasimhan
received the King Faizal International prize 2006 for his
contributions to differential geometry and algebraic geometry
which strengthened the link between mathematics and physics.
He is one of the principal leaders responsible for developing
the school of mathematics at the Tata Institute of Fundamental
Research (TIFR), Mumbai. His research proved useful in fields
such as Gauge theory and conformal field theory in physics.
(The Hindu, 05.05.2006)

|
|
A significant part of the
chip design and development has been achieved by Indian
hardware engineers. They have been working at a
Bangalore-based development centre of German chipmaker
Infineon and with Infineon co-workers in Munich and Duisburg.
It is the first chip for mobile applications that has been
fabricated using 65 nanometre technology. The chip packs over
30 million transistors without asking for more battery power.
Samsung and IBM have partnered in the project.
(The Hindu, 17.05.2006)

|
|
The intensity of the
European contacts with India in the area of the science,
education and innovation is on further increase. In this
context a German Indian Workshop is planned for 29.07.2006 on
the subject "Clean room Technology and related fields ". The
workshop is a sequel to the workshop on “Mass Healthcare and
Infrastructure Support: Role of Biomechanics and its
Industrial Approach" organized by the IIT in collaboration
with the Indian Ministry of Science & technology in India last
year. In addition, the Julius Maximilian's university of
Würzburg in collaboration with the delegation of the European
Union for India, the German Embassy (New Delhi) and the
Federal Ministry of education and research is organizing a
Roadshow about tele-education in the robotics from the 9th to
the 15th of October, 2006 in New Delhi, Kanpur, Bombay and
Bangalore.
(http://www7.informatik.uni-wuerzburg.de/roadshow
,
www.internationale-kooperation.de)

|
|
This newsletter has been prepared by the
Science Section of the Embassy of the Federal Republic of
Germany, New Delhi. Texts of articles from science magazines
and newspapers have been edited for their length and are
partly based on information from the Embassy. No
responsibility for the content of the articles is accepted.
|
|
|